TTNP β€” TITAN PHARMACEUTICALS INC DE

Ownership history in UBS Group AG  Β·  7 quarters on record

This page tracks every 13F SEC filing in which UBS Group AG reported a position in TITAN PHARMACEUTICALS INC DE (TTNP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 7 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 480 -2,947 -86.0% 0.00% $2K β€”
2025 Q2 ADDED 3,427 +833 +32.1% 0.00% $14K β€”
2025 Q1 REDUCED 2,594 -73 -2.7% 0.00% $9K β€”
2024 Q4 REDUCED 2,667 -2,106 -44.1% 0.00% $9K β€”
2024 Q3 ADDED 4,773 +4,772 +477200.0% 0.00% $25K β€”
2024 Q2 UNCHANGED 1 β€” 0% 0.00% $6 β€”
2024 Q1 INITIATED 1 β€” β€” 0.00% $7 β€”

🏒 Other funds also holding TTNP

As of 2025 Q4 β€” sorted by position size

CoreCap Advisors, LLC 3Y 0.0% CALDWELL SUTTER CAPITAL, INC. 3Y 0.0% Global Wealth Strategies & Associates 3Y 0.0% ST GERMAIN D J CO INC 3Y 7Y 0.0%
← Back to UBS Group AG Holdings